Botulinum toxin type A in the healing of chronic lesion following bilateral spasticity of gluteus muscle.
Use of botulinum toxin is expanding as the clinical studies demonstrate new potential therapeutic applications. In rehabilitation, botulinum toxin is above all used as adjunct therapy for the treatment of spasticity, but it may prove useful for other atypical clinical situations. A 17-year-old man had a sub-arachnoid haemorrhage following the rupture of cerebral aneurism. The patient presented gluteus maximus and medius bilaterally spasticity that produced a chronic lesion in the intergluteal cleft, a flexed wrist and a flexed elbow. As treatment for this spasticity, a total of 100 U botulinum toxin type A were injected into the glutei muscles. This treatment allowed for application of topical medication and subsequently, chronic lesion healing. Botulinum toxin A may be an important therapeutic aid for clinicians faced with treating persistent pathological conditions caused by spasticity.
Department of Plastic and Reconstructive Surgery, 'Sapienza' University, Viale del Policlinico, Rome, Italy.
Emanuele
E
Cigna
Michele
M
Maruccia
Benedetta
B
Fanelli
Nicolò
N
Scuderi
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002081:Buttocks; D002908:Chronic Disease; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009128:Muscle Spasticity / Q000150:complications* / Q000188:drug therapy; D009465:Neuromuscular Agents / Q000008:administration & dosage; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D014945:Wound Healing / Q000187:drug effects*; D055815:Young Adult
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A